The quantitative PCR (qPCR) market size is expected to grow from US$ 2.57 billion in 2023 to US$ 4.82 billion by 2031; the market is anticipated to register a CAGR of 8.2% during 2023-2031.

qPCR is also termed real-time PCR, as it facilitates the monitoring of the progression of a reaction in real time. In traditional PCR, DNA is amplified via multiple cycles of three repeating steps: denaturation, annealing, and elongation. In addition to the common reagents, a fluorophore is added to the sample when performing qPCR, which enables the collection of data in real time as PCR progresses. qPCR is extensively used for diagnostic and research purposes. The quantitative PCR (qPCR) market growth is attributed to the technological advancements in qPCR technologies and the growing demand for qPCR in infectious disease diagnosis. However, high costs associated with real-time PCR systems hinder the growth of the quantitative PCR (qPCR) market.

Increasing efforts by PCR manufacturers to create innovative real-time PCR instrument systems and kits for molecular testing are expected to provide expansion opportunities in the quantitative PCR (qPCR) market.

In November 2020, Streck launched a novel qPCR instrument, Zulu RT, a rapid, modular qPCR instrument that can be used to perform four independent experiments simultaneously. It can perform a 40-cycle, 6-channel, 3-step real-time PCR in less than 20 minutes, making it the quickest qPCR instrument in the world. The greater flexibility of the instrument helps capture a share of the market.

In February 2022, New England Biolabs released its first lyophilized product manufactured by Fluorogenics: the LyoPrime Luna Probe One-Step RT-qPCR Mix with UDG. This lyophilized master mix enables sensitive, linear, real-time detection of target RNA sequences in a room temperature-stable format.

In February 2023, Thermo Fisher launched real-time PCR kits in India for the detection of infectious diseases. Designed to deliver confidence and reliability for diagnostic development and testing, the TaqPath PCR kits by Applied Biosystems for infectious diseases received licensing rights from the Central Drugs Standard Control Organisation and are manufactured in India in association with Pune-based Mylab Discovery Solutions.

In November 2023, Roche launched the LightCycler PRO System based on the proven gold standard technology for its previously introduced LightCycler Systems. The new system complements Roche's molecular PCR testing portfolio, which includes solutions for a diversity of healthcare professionals- from those performing research to those testing patients for infectious diseases, cancer, and other public health challenges.

Thus, such strategic initiatives by the market players are likely to provide new opportunities for the growth of the quantitative PCR (qPCR) market.

Application-Based Insights

Based on application, the quantitative PCR (qPCR) market is categorized into research, clinical, and forensics. The clinical segment held a significant quantitative PCR (qPCR) market share in 2023 and is projected to register the highest CAGR during the forecast period. qPCR technologies have been used in procedures to detect mutations in genes, which helps diagnose cancer. The qPCR technique is being used in the diagnosis of many diseases, including infectious diseases and noncommunicable diseases such as diabetes.

End User-Based Insights

Based on end user, the quantitative PCR (qPCR) market is categorized into hospitals and diagnostic centers, forensic laboratories, pharmaceutical and biotechnology companies, research laboratories and academic institutes, and clinical research organizations. The hospitals and diagnostic centers segment held a significant quantitative PCR (qPCR) market share in 2023 and is estimated to register the highest CAGR during 2023-2031. Hospitals offer innovative diagnosis and treatment choices for patients to treat acute and chronic conditions, and the adoption of PCR techniques is considerably higher in hospitals and diagnostic centers as they provide healthcare facilities with specialized scientific equipment, which positively influences the quantitative PCR (qPCR) market growth.

The World Health Organization, Global Cancer Observatory, and the Centers for Disease Control and Prevention are among the primary and secondary sources referred to while preparing the quantitative PCR (qPCR) market report.